Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Artiva Biotherapeutics, Inc. - Common Stock (NQ:ARTV)

2.930 -0.020 (-0.68%)
Streaming Delayed Price Updated: 3:34 PM EDT, Oct 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 26,843
Open 2.970
Bid (Size) 2.920 (1)
Ask (Size) 2.950 (2)
Prev. Close 2.950
Today's Range 2.915 - 3.000
52wk Range 1.470 - 16.87
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Artiva Biotherapeutics to Participate in the Cantor Global Healthcare Conference 2025
From Artiva Biotherapeutics, Inc.
Via GlobeNewswire

Performance

YTD
-70.6%
-70.6%
1 Month
-18.8%
-18.8%
3 Month
+85.4%
+85.4%
6 Month
-11.5%
-11.5%
1 Year
-79.8%
-79.8%

More News

Read More
Artiva (ARTV) Q2 Loss Widens 19.7%
Via The Motley Fool
Artiva Biotherapeutics Reports Second Quarter 2025 Financial Results, Recent Business Highlights
From Artiva Biotherapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Artiva Biotherapeutics to Participate in the Jefferies Global Healthcare Conference
From Artiva Biotherapeutics, Inc.
Via GlobeNewswire
Artiva Biotherapeutics Announces Longer-term Phase 1/2 Data Demonstrating Prolonged Durability for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting
From Artiva Biotherapeutics, Inc.
Via GlobeNewswire
Artiva Biotherapeutics Reports First Quarter 2025 Financial Results, Recent Business Highlights
From Artiva Biotherapeutics, Inc.
Via GlobeNewswire
Artiva Biotherapeutics to Present Longer-term Phase 1/2 Data for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting
From Artiva Biotherapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Which stocks are moving on Tuesday?
Via Chartmill
Artiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as Chief Medical Officer
From Artiva Biotherapeutics, Inc.
Via GlobeNewswire
These stocks have an unusual volume in today's session
Via Chartmill
Which stocks are experiencing notable movement on Tuesday?
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Traders are paying attention to the gapping stocks in Tuesday's session.
Via Chartmill
Which stocks are moving on Monday?
Via Chartmill
Keep an eye on the top gainers and losers in Monday's session.
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Artiva Biotherapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
From Artiva Biotherapeutics, Inc.
Via GlobeNewswire
Goldman Sachs To Rally Around 8%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Artiva Biotherapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights
From Artiva Biotherapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Artiva Biotherapeutics to Participate in the TD Cowen 45th Annual Health Care Conference
From Artiva Biotherapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga

Frequently Asked Questions

Is Artiva Biotherapeutics, Inc. - Common Stock publicly traded?
Yes, Artiva Biotherapeutics, Inc. - Common Stock is publicly traded.
What exchange does Artiva Biotherapeutics, Inc. - Common Stock trade on?
Artiva Biotherapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Artiva Biotherapeutics, Inc. - Common Stock?
The ticker symbol for Artiva Biotherapeutics, Inc. - Common Stock is ARTV on the Nasdaq Stock Market
What is the current price of Artiva Biotherapeutics, Inc. - Common Stock?
The current price of Artiva Biotherapeutics, Inc. - Common Stock is 2.930
When was Artiva Biotherapeutics, Inc. - Common Stock last traded?
The last trade of Artiva Biotherapeutics, Inc. - Common Stock was at 10/06/25 03:34 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.